Cantor Fitzgerald initiated coverage on shares of Acadia Healthcare (NASDAQ: ACHC) in a research note issued on Tuesday. The firm set a “buy” rating and a $35.00 price target on the stock.

Several other analysts have also recently commented on the stock. Analysts at Zacks downgraded shares of Acadia Healthcare from an “outperform” rating to a “neutral” rating in a research note to investors on Tuesday, February 26th. They now have a $28.50 price target on the stock. Separately, analysts at Raymond James raised their price target on shares of Acadia Healthcare from $27.00 to $30.00 in a research note to investors on Friday, February 22nd. Finally, analysts at BMO Capital Markets reiterated an “outperform” rating on shares of Acadia Healthcare in a research note to investors on Friday, February 22nd. They now have a $34.00 price target on the stock, up previously from $27.00.

Seven research analysts have rated the stock with a buy rating, three have assigned an overweight rating, and one has issued a hold rating to the stock. The company currently has an average rating of “buy” and an average price target of $30.45.

Shares of Acadia Healthcare traded up 0.04% during mid-day trading on Tuesday, hitting $28.04. Acadia Healthcare has a 52 week low of $14.40 and a 52 week high of $28.50. The stock’s 50-day moving average is currently $26.49. The company has a market cap of $1.408 billion and a P/E ratio of 53.19.

Acadia Healthcare Company, Inc. is a provider of inpatient behavioral health care services in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.